Atef, Y.; Ito, T.; Masuda, A.; Kato, Y.; Nishimura, A.; Kanda, Y.; Kunisawa, J.; Kusakabe, T.; Nishida, M.
Diabetic Mice Spleen Vulnerability Contributes to Decreased Persistence of Antibody Production after SARS-CoV-2 Vaccine. Int. J. Mol. Sci. 2024, 25, 10379.
https://doi.org/10.3390/ijms251910379
AMA Style
Atef Y, Ito T, Masuda A, Kato Y, Nishimura A, Kanda Y, Kunisawa J, Kusakabe T, Nishida M.
Diabetic Mice Spleen Vulnerability Contributes to Decreased Persistence of Antibody Production after SARS-CoV-2 Vaccine. International Journal of Molecular Sciences. 2024; 25(19):10379.
https://doi.org/10.3390/ijms251910379
Chicago/Turabian Style
Atef, Yara, Tomoya Ito, Akitsu Masuda, Yuri Kato, Akiyuki Nishimura, Yasunari Kanda, Jun Kunisawa, Takahiro Kusakabe, and Motohiro Nishida.
2024. "Diabetic Mice Spleen Vulnerability Contributes to Decreased Persistence of Antibody Production after SARS-CoV-2 Vaccine" International Journal of Molecular Sciences 25, no. 19: 10379.
https://doi.org/10.3390/ijms251910379
APA Style
Atef, Y., Ito, T., Masuda, A., Kato, Y., Nishimura, A., Kanda, Y., Kunisawa, J., Kusakabe, T., & Nishida, M.
(2024). Diabetic Mice Spleen Vulnerability Contributes to Decreased Persistence of Antibody Production after SARS-CoV-2 Vaccine. International Journal of Molecular Sciences, 25(19), 10379.
https://doi.org/10.3390/ijms251910379